Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
+$0.06 today
- Market cap
- $184.70M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
Volume 0.28M
Average 0.31M
WHWK Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Whitehawk Therapeutics IncNASDAQ: WHWK
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock broadly unchanged from a year ago
Common stock stood at $4K at the end of Q1 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +26.0% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 4K USD
- Year-over-year change
- +100.0%
- 4-year CAGR
- +18.9%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4K | +100.0% |
| FY2024 | 2024-12-31 | 2K | +0.0% |
| FY2023 | 2023-12-31 | 2K | +0.0% |
| FY2022 | 2022-12-31 | 2K | +0.0% |
| FY2021 | 2021-12-31 | 2K | — |
Common Stock vs competitors
How WHWK compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +0.0% is the 6th highest of 9, against a peer median of +1.6%.
- Common stock amounts to 0.0% of total assets for WHWK, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $12.01M USD | +1200500.0% | -47.7% | 55.4% | |
| Mar 2026 | $636K USD | +0.8% | +0.9% | 0.3% | |
| Mar 2026 | $167K USD | +135.2% | +22.6% | 0.1% | |
| Mar 2026 | $91.88K USD | +2.4% | +79.2% | 0.2% | |
| Mar 2026 | $71K USD | -1.4% | +5.4% | 0.0% | |
| Mar 2026 | $6K USD | +0.0% | +6.3% | 0.0% | |
| Mar 2026 | $5.31K USD | +90.0% | +56.0% | 0.0% | |
WHWKWhitehawk Therapeutics Inc | Mar 2026 | $4K USD | +0.0% | +26.0% | 0.0% |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding WHWK) | — | +1.6% | +6.3% | 0.1% | |
Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 148.99M | 39.02M | 62.89M | 28.67M | 37.57M |
| Short-term Investments | 0 | 133.54M | 45.96M | 18.57M | 108.13M |
| Net Receivables | 0 | 1.86M | 5.49M | 5.9M | 0 |
| Inventory | 0 | 1.86M | 6.43M | 5.31M | 0 |
| Other Current Assets | 0 | 0 | 3.83M | 0 | 3.32M |
| Total Current Assets | 151.27M | 180.03M | 124.59M | 61.29M | 149.01M |
| Property, Plant & Equipment (Net) | 614K | 2.03M | 5.97M | 7.63M | 3K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.81M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.21M | 2.18M | 1.87M | 1.4M | 1.81M |
| Total Non-current Assets | 6.64M | 4.21M | 7.84M | 9.03M | 1.82M |
| Total Assets | 157.91M | 184.24M | 132.42M | 70.32M | 150.83M |
| Account Payables | 6.44M | 3.52M | 5.9M | 2.16M | 917K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.47M | 1.57M | 3.08M | 64K | 3.16M |
| Total Current Liabilities | 15.27M | 18.84M | 26.4M | 17.07M | 14.52M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.76M | 5.76M | 0 | 202K | 0 |
| Total Non-current Liabilities | 6.23M | 7.02M | 833K | 767K | 0 |
| Total Liabilities | 21.5M | 25.86M | 27.23M | 17.84M | 14.52M |
| Common Stock | 2K | 2K | 2K | 2K | 4K |
| Retained Earnings | (142.69M) | (203.2M) | (268.96M) | (332.65M) | (353.25M) |
| Accumulated OCI | 0 | (115K) | 27K | 16K | 120K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 136.41M | 158.38M | 105.2M | 52.48M | 136.31M |
| Total Debt | 605K | 1.66M | 1.27M | 833K | 0 |
| Net Debt | (148.38M) | (37.36M) | (61.62M) | (27.84M) | (37.57M) |
Whitehawk Therapeutics Inc
NASDAQ:WHWK
Intrinsic Alpha fair value
Locked
Current Price
$3.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.